AI assistant
Solid Biosciences Inc. — Director's Dealing 2025
Jul 9, 2025
33003_dirs_2025-07-08_ec815756-2f2d-44ba-a332-73b565763543.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2025-07-06
Reporting Person: SMITH IAN F (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-06 | Common Stock | M | 4573 | — | Acquired | 122119 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-07-06 | Restricted Stock Units | $ | M | 4573 | Disposed | Common Stock (4573) | Direct |
Footnotes
F1: Restricted stock units convert to common stock on a one-for-one basis.
F2: The restricted stock units were granted on January 6, 2025 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Third Amendment to Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full.